Currently, the share price for Piramal Pharma Ltd. is delayed. Login to view live prices.
Piramal Pharma Ltd.
₹273.45
NSE
-- ( -- %) 1D
- Prev. Close273.45
- Upper Circuit328.10
- Lower Circuit218.80
Analyst Sentiment For Piramal Pharma Ltd.
As recommended by 6 analysts
Returns
Piramal Pharma Ltd.'s Info & Management
Piramal Pharma is a leading pharmaceutical company with global operations, providing end-to-end pharma services to customers and a portfolio of differentiated products across a domestic and global distribution network. We operate under three business verticals - Piramal Pharma Solutions, an integrated contract development and manufacturing organization (“CDMO”) havingaproductsuiteinnicheareassuchashighlypotent Active pharmaceutical ingredients ('APIs'), Finished dosage forms ('FDFs'), antibody drug conjugates, potent sterile injectable, hormonal oral solid dosage forms, biologics and vaccines; Piramal Critical Care, a complex hospital generics (“CHG”) business in the areas of inhalation anaesthesia, injectable anaesthesia and pain management, intrathecal therapy and other injectable; and India consumer healthcare (“ICH”) business, selling well-known OTC brands.
- Executive Director,Chief Financial OfficerMr. Vivek Valsaraj
- Company Secretary,Compliance OfficerTanya Sanish
- Chief Operating OfficerMr. Herve Berdou
- Chief Commercial Officer,Chief(Patient Services)Mr. Stuart Needleman
- President,Chief Operating OfficerMr. Jeffrey Hampton
- Chief Executive Officer(Consumer Products Business)Mr. Nitish Bajaj
FAQs on Piramal Pharma Ltd.
What is the share price of Piramal Pharma Ltd.?
Piramal Pharma Ltd. share price is ₹268.65 as of December 3, 2024, 03:29 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).
What is the 52-week high and low of Piramal Pharma Ltd.?
The 52-week high and low of Piramal Pharma Ltd. is ₹307.75 and ₹114.35 respectively as of December 3, 2024, 03:29 PM.
52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).
What is the PB ratio of Piramal Pharma Ltd.?
The trailing twelve month (TTM) PB ratio of Piramal Pharma Ltd. is 4.57 as of December 4, 2024. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.
What are the Upper Circuit and Lower Circuit of Piramal Pharma Ltd.?
The Upper Circuit of Piramal Pharma Ltd. is ₹328.
The Lower Circuit of Piramal Pharma Ltd. is ₹219.
What is the ROE of Piramal Pharma Ltd.?
Piramal Pharma Ltd. reported an ROE of 0.24% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.
What is the shareholding pattern of Piramal Pharma Ltd.?
Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Piramal Pharma Ltd., Promoter held 35%, the FII held 31.7%, DII held 13.8% and the public held 19.1% of the total shares.
How to buy Piramal Pharma Ltd. Share?
You can easily buy shares of Piramal Pharma Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.
What is the fair value of Piramal Pharma Ltd.?
The fair value of Piramal Pharma Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer